T1-T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents
- PMID: 28613821
- PMCID: PMC9617470
- DOI: 10.1021/acsnano.7b03075
T1-T2 Dual-Modal Magnetic Resonance Imaging: From Molecular Basis to Contrast Agents
Abstract
Multimodal imaging strategies integrating manifold images have improved our ability to diagnose, to guide therapy, and to predict outcomes. Magnetic resonance imaging (MRI) is among the most widely used imaging technique in the clinic and can enable multiparameter anatomical demonstration of diagnosis. Due to the inherent black-and-white production of MR images, however, MRI detection is largely hampered by the occurrence of false-positive diagnoses. In this Perspective, we introduce the paradigm of manipulating the multiparameter MRI, T1-T2 dual-modal MRI, along with enhancement by specific contrast agents. We hope this discussion will promote emerging research interest in T1-T2 dual-modal MRI and provoke the rational design of contrast agents for sophisticated MRI applications.
Conflict of interest statement
The authors declare no competing financial interests.
Figures

References
-
- Weissleder R Molecular Imaging in Cancer. Science 2006, 312, 1168–1171. - PubMed
-
- Willmann JK; van Bruggen N; Dinkelborg LM; Gambhir SS Molecular Imaging in Drug Development. Nat. Rev. Drug Discov 2008, 7, 591–607. - PubMed
-
- Weissman NJ; Soman P; Shah DJ Multimodality Imaging: Opportunities and Challenges. JACC: Cardiovascular Imaging 2013, 6, 1022–1023. - PubMed
-
- Sauter AW; Wehrl HF; Kolb A; Judenhofer MS; Pichler BJ Combined PET/MRI: One Step Further in Multimodality Imaging. Trends Mol. Med 2010, 16, 508–515. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical